Arbutus Biopharma Corp (ABUS) Net income 2016–2025
Arbutus Biopharma Corp (ABUS) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$33.5MFY2025 · since FY2016: -$384.2M → -$33.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$33.5M | +52.1% |
| FY2024 | -$69.9M | +4.0% |
| FY2023 | -$72.8M | -4.9% |
| FY2022 | -$69.5M | +8.9% |
| FY2021 | -$76.2M | -19.6% |
| FY2020 | -$63.7M | +58.5% |
| FY2019 | -$153.7M | -169.4% |
| FY2018 | -$57.1M | +32.4% |
| FY2017 | -$84.4M | +78.0% |
| FY2016 | -$384.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice